Search Results - Alessandra Rustighi
- Showing 1 - 6 results of 6
-
1
-
2
Erratum To: Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast by Alessandra Rustighi, Alessandro Zannini, Luca Tiberi, Roberta Sommaggio, Silvano Piazza, Giovanni Sorrentino, Simona Nuzzo, Antonella Tuscano, Vincenzo Eterno, Federica Benvenuti, Libero Santarpia, Iannis Aifantis, Antonio Rosato, Silvio Bicciato, Alberto Zambelli, Giannino Del Sal
Published in EMBO Molecular Medicine (2014-05-01)Get full text
Article -
3
Prolyl‐isomerase Pin1 controls normal and cancer stem cells of the breast by Alessandra Rustighi, Alessandro Zannini, Luca Tiberi, Roberta Sommaggio, Silvano Piazza, Giovanni Sorrentino, Simona Nuzzo, Antonella Tuscano, Vincenzo Eterno, Federica Benvenuti, Libero Santarpia, Iannis Aifantis, Antonio Rosato, Silvio Bicciato, Alberto Zambelli, Giannino Del Sal
Published in EMBO Molecular Medicine (2013-12-01)Get full text
Article -
4
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth by Camilla Tombari, Alessandro Zannini, Rebecca Bertolio, Silvia Pedretti, Matteo Audano, Luca Triboli, Valeria Cancila, Davide Vacca, Manuel Caputo, Sara Donzelli, Ilenia Segatto, Simone Vodret, Silvano Piazza, Alessandra Rustighi, Fiamma Mantovani, Barbara Belletti, Gustavo Baldassarre, Giovanni Blandino, Claudio Tripodo, Silvio Bicciato, Nico Mitro, Giannino Del Sal
Published in Nature Communications (2023-11-01)Get full text
Article -
5
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth by Camilla Tombari, Alessandro Zannini, Rebecca Bertolio, Silvia Pedretti, Matteo Audano, Luca Triboli, Valeria Cancila, Davide Vacca, Manuel Caputo, Sara Donzelli, Ilenia Segatto, Simone Vodret, Silvano Piazza, Alessandra Rustighi, Fiamma Mantovani, Barbara Belletti, Gustavo Baldassarre, Giovanni Blandino, Claudio Tripodo, Silvio Bicciato, Nico Mitro, Giannino Del Sal
Published in Nature Communications (2023-10-01)Get full text
Article -
6
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening by Ambra Cappelletto, Edoardo Alfì, Nina Volf, Thi Van Anh Vu, Francesca Bortolotti, Giulio Ciucci, Simone Vodret, Marco Fantuz, Martina Perin, Andrea Colliva, Giacomo Rozzi, Matilde Rossi, Giulia Ruozi, Lorena Zentilin, Roman Vuerich, Daniele Borin, Romano Lapasin, Silvano Piazza, Mattia Chiesa, Daniela Lorizio, Luca Triboli, Sandeep Kumar, Gaia Morello, Claudio Tripodo, Maurizio Pinamonti, Giulia Maria Piperno, Federica Benvenuti, Alessandra Rustighi, Hanjoong Jo, Stefano Piccolo, Giannino Del Sal, Alessandro Carrer, Mauro Giacca, Serena Zacchigna
Published in Journal of Experimental & Clinical Cancer Research (2024-01-01)Get full text
Article
